Palvella Therapeutics (PVLA) Revenue Growth (3y) (2017 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -84.02% |
| Sep 30, 2023 | 74.32% |
| Jun 30, 2023 | 21.27% |
| Mar 31, 2023 | -47.34% |
| Sep 30, 2022 | -74.26% |
| Jun 30, 2022 | -13.36% |
| Mar 31, 2022 | 8.74% |
| Dec 31, 2021 | 102.27% |
| Sep 30, 2021 | -30.65% |
| Jun 30, 2021 | -39.88% |
| Mar 31, 2021 | 46.29% |
| Dec 31, 2020 | -53.06% |
| Sep 30, 2020 | -9.21% |
| Jun 30, 2020 | 82.41% |
| Mar 31, 2020 | 114.54% |
| Dec 31, 2019 | 3.88% |
| Sep 30, 2019 | 168.13% |
| Jun 30, 2019 | 70.65% |
| Mar 31, 2019 | 89.96% |
| Dec 31, 2018 | 50.63% |
| Sep 30, 2018 | 172.02% |
| Jun 30, 2018 | 317.85% |
| Mar 31, 2018 | 167.21% |
| Sep 30, 2017 | 494.14% |
| Jun 30, 2017 | 38.45% |